MwanzoAMG • ETR
add
Amgen Inc
Bei iliyotangulia
€ 241.45
Bei za siku
€ 239.60 - € 241.20
Bei za mwaka
€ 230.75 - € 318.05
Thamani ya kampuni katika soko
149.01B USD
Wastani wa hisa zilizouzwa
423.00
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 8.15B | 9.43% |
Matumizi ya uendeshaji wa biashara | 3.20B | 0.47% |
Mapato halisi | 1.73B | 1,630.97% |
Kiwango cha faida halisi | 21.23 | 1,496.71% |
Mapato kwa kila hisa | 4.90 | 23.74% |
EBITDA | 3.52B | 19.29% |
Asilimia ya kodi ya mapato | 12.32% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 8.81B | -9.25% |
Jumla ya mali | 89.37B | -3.89% |
Jumla ya dhima | 83.16B | -5.45% |
Jumla ya hisa | 6.21B | — |
hisa zilizosalia | 537.71M | — |
Uwiano wa bei na thamani | 20.92 | — |
Faida inayotokana na mali | 6.46% | — |
Faida inayotokana mtaji | 8.98% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 1.73B | 1,630.97% |
Pesa kutokana na shughuli | 1.39B | 101.89% |
Pesa kutokana na uwekezaji | -447.00M | -105.99% |
Pesa kutokana na ufadhili | -4.11B | -140.46% |
Mabadiliko halisi ya pesa taslimu | -3.16B | -155.91% |
Mtiririko huru wa pesa | 1.21B | -34.48% |
Kuhusu
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue.
The company's major products are Prolia and XGEVA for treatment of osteoporosis and bone diseases, Enbrel for treatment of autoimmune diseases, Repatha for treatment of hyperlipidemia, Otezla for treatment of psoriasis and psoriatic arthritis, Tepezza to treat Graves' ophthalmopathy, Evenity to treat osteoporosis, Kyprolis to treat cancer, Nplate to regulate platelet production, and Aranesp Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
8 Apr 1980
Makao Makuu
Tovuti
Wafanyakazi
28,000
